Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 26/11/2020
SIETES contiene 93166 citas

 
 
 1 a 20 de 7728 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Parsons L. AZ’s COVID-19 vaccine demonstrates efficacy rate of up to 90%. PMLiVE 2020:23 de noviembre. [Ref.ID 103787]
2. Cita con resumen
Callaway E. COVID vaccine excitement builds as Moderna reports third positive result. Nature Briefing 2020:1. [Ref.ID 103777]
3.Tiene citas relacionadas Cita con resumen
Parsons L. Russia claims its COVID-19 vaccine is over 90% effective. PMLiVE 2020:1. [Ref.ID 103771]
4.Enlace a cita original Cita con resumen
WHO Solidarity trial consortium. Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results. medRxiv 2020:15 de octubre. [Ref.ID 103745]
5. Cita con resumen
Anónimo. CDER proposes withdrawal of approval for Makena . U.S. Food and Drug Administration 2020:10 de mayo. [Ref.ID 103725]
6. Cita con resumen
Doshi P, Topol E. These coronavirus trials don’t answer the one question we need to know. N Y Times (Print) 2020:22 de septiembre. [Ref.ID 103722]
7.Enlace a cita originalTiene citas relacionadas Cita con resumen
Avorn J, Kesselheim AS. Up Is down — Pharmaceutical industry caution vs. Federal acceleration of Covid-19 vaccine approval. N Engl J Med 2020;383:29 de octubre. [Ref.ID 103719]
9. Cita con resumen
Kramer AE. Russia approves coronavirus vaccine before completing tests. N Y Times (Print) 2020:11 de agosto. [Ref.ID 103704]
10.Enlace a cita originalTiene citas relacionadas Cita con resumen
Moynihan R, MacDonald H, Bero L, Godlee F. Commercial influence and covid-19. BMJ 2020;369:24 de junio. [Ref.ID 103680]
11. Cita con resumen
Rome BN, Avorn J. Drug evaluation during the covid-19 pandemic. N Engl J Med 2020;382:11 de junio. [Ref.ID 103661]
13. Cita con resumen
Di Maio M, Audisio M, Cardone C, De Luca E, Gargiulo P, Zichi C, Perrone F. The use of not-negative conclusions to describe results of formally negative trials presented at oncology meetings. JAMA Oncology 2020:1. [Ref.ID 103598]
14. Cita con resumen
Anderson TS, Odden MC, Penko J, et al.. Generalizability of clinical trials supporting the 2017 American College of Cardiology/American Heart Association blood pressure guideline. JAMA Intern Med 2020:16 de marzo. [Ref.ID 103580]
16.Tiene citas relacionadas Cita con resumen
Dyer O. Cochrane reviewer sues Roche for claiming Tamiflu could slow flu pandemic. BMJ 2020;368:31 de enero. [Ref.ID 103541]
17. Cita con resumen
Hripcsak G, Suchard MA, Shea S, Chen RJ, You SC, Pratt N, Madigan D, Krumholz HM, Ryan PB, Schuemie MJ. Comparison of cardiovascular and safety outcomes of chlorthalidone vs hydrochlorothiazide to treat hypertension. JAMA Intern Med 2020:17 de febrero. [Ref.ID 103537]
18. Cita con resumen
Sys J, Van Cleynenbreugel S, Deschodt M, Van der Linden L, Tournoy J. Efficacy and safety of non-benzodiazepine and non-Z-drug hypnotic medication for insomnia in older people: a systematic literature review. Eur J Clin Pharmacol 2020;76:marzo. [Ref.ID 103530]
19. Cita con resumen
Butler CC, van der Velden AW, Bongard E, Saville BR, Holmes J, Coenen S, Cook J, et al.. Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial. Lancet 2020;395:4 de enero. [Ref.ID 103501]
Seleccionar todas
 
 1 a 20 de 7728 siguiente >>